Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)

SHA:603229 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 15, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,687	8,295	7,834	9,564	10,451	8,765
Market Cap Growth	13.82%	5.87%	-18.09%	-8.49%	19.25%	170.38%
Enterprise Value	6,869	7,572	7,115	9,183	9,848	8,455
Last Close Price	9.28	9.99	9.32	11.93	13.01	10.89
PE Ratio	36.47	40.11	30.86	40.64	71.62	100.93
Forward PE	-	16.29	22.58	34.87	54.34	11.21
PS Ratio	9.60	10.43	9.59	12.51	18.35	21.42
PB Ratio	3.24	3.65	3.66	6.55	8.33	7.78
P/TBV Ratio	3.47	3.92	3.94	7.36	9.58	8.35
P/FCF Ratio	273.05	124.50	134.20	-	-	192.56
P/OCF Ratio	50.24	46.62	35.32	79.33	60.10	63.30
EV/Sales Ratio	8.58	9.52	8.71	12.01	17.29	20.66
EV/EBITDA Ratio	27.01	30.50	24.96	38.32	54.04	62.95
EV/EBIT Ratio	37.08	40.78	29.10	44.75	64.70	77.65
EV/FCF Ratio	244.00	113.66	121.89	-	-	185.75
Debt / Equity Ratio	0.12	0.12	0.14	0.17	0.09	0.04
Debt / EBITDA Ratio	1.15	1.09	1.06	1.01	0.60	0.31
Debt / FCF Ratio	10.37	4.09	5.19	-	-	0.90
Asset Turnover	0.26	0.27	0.31	0.37	0.35	0.36
Inventory Turnover	1.06	0.98	1.09	1.32	1.21	0.97
Quick Ratio	2.02	1.92	1.63	1.01	1.40	3.22
Current Ratio	2.57	2.53	2.17	1.53	1.92	4.02
Return on Equity (ROE)	9.21%	9.37%	14.09%	17.33%	12.25%	9.80%
Return on Assets (ROA)	3.76%	3.91%	5.80%	6.17%	5.91%	6.00%
Return on Capital (ROIC)	4.43%	4.65%	7.37%	8.36%	7.51%	7.32%
Return on Capital Employed (ROCE)	7.70%	8.00%	11.20%	13.10%	11.60%	9.60%
Earnings Yield	2.78%	2.49%	3.24%	2.46%	1.40%	0.99%
FCF Yield	0.37%	0.80%	0.74%	-1.58%	-1.31%	0.52%
Dividend Yield	1.07%	1.00%	0.99%	0.48%	0.29%	0.21%
Payout Ratio	39.30%	40.73%	22.63%	16.00%	13.69%	15.43%
Buyback Yield / Dilution	-2.96%	-0.99%	-1.92%	-1.16%	-6.67%	-0.25%
Total Shareholder Return	-1.90%	0.01%	-0.93%	-0.68%	-6.38%	-0.04%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.